China National Medicines Corporation Ltd. (SHA:600511)
China
· Delayed Price · Currency is CNY 28.70
-0.06 (-0.21%)
Apr 29, 2026, 11:29 AM CST
SHA:600511 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 2,012 | 1,997 | 2,000 | 2,146 | 1,964 | 1,754 | Upgrade
|
| Depreciation & Amortization | 229.04 | 229.04 | 240.54 | 199.75 | 189.61 | 178.83 | Upgrade
|
| Other Amortization | 19.25 | 19.25 | 9.53 | 8.57 | 7.84 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.21 | -0.21 | 0.19 | -0.08 | -1.68 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.1 | 0.1 | 0 | 0.05 | 5.23 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -585.38 | -585.38 | -532.08 | -369.77 | -291.62 | - | Upgrade
|
| Provision & Write-off of Bad Debts | 34.1 | 34.1 | 22.82 | 9.17 | 23.8 | - | Upgrade
|
| Other Operating Activities | -1,589 | 125.54 | 164.38 | 228.17 | 203.37 | 24.54 | Upgrade
|
| Change in Accounts Receivable | -692.57 | -692.57 | -442.42 | -292.55 | 599.77 | - | Upgrade
|
| Change in Inventory | -240.87 | -240.87 | -993.86 | -243.6 | -207.59 | - | Upgrade
|
| Change in Accounts Payable | 1,140 | 1,140 | 1,218 | 1,048 | -87.62 | - | Upgrade
|
| Operating Cash Flow | 305.74 | 2,006 | 1,659 | 2,727 | 2,395 | 1,957 | Upgrade
|
| Operating Cash Flow Growth | -79.42% | 20.88% | -39.15% | 13.84% | 22.36% | 50.38% | Upgrade
|
| Capital Expenditures | -67.26 | -68.19 | -130.77 | -145.12 | -129.78 | -95.07 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.17 | 0.2 | 0.39 | 0.16 | 3.52 | 0.78 | Upgrade
|
| Cash Acquisitions | - | - | - | - | -15.2 | -15.82 | Upgrade
|
| Investment in Securities | 18.28 | 18.33 | -2,477 | 7.88 | -12.6 | -15.75 | Upgrade
|
| Other Investing Activities | 32.27 | 32.27 | 23.75 | 7.77 | 1.74 | 2.86 | Upgrade
|
| Investing Cash Flow | -16.53 | -17.39 | -2,584 | -129.31 | -152.32 | -122.99 | Upgrade
|
| Short-Term Debt Issued | - | 319.45 | 315.98 | 203.2 | 335.61 | 793.18 | Upgrade
|
| Total Debt Issued | 325.45 | 319.45 | 315.98 | 203.2 | 335.61 | 793.18 | Upgrade
|
| Short-Term Debt Repaid | - | -923.45 | -1,033 | -250 | -509.86 | -864.55 | Upgrade
|
| Long-Term Debt Repaid | - | -117.09 | -117.81 | -81.71 | -117.07 | -72.35 | Upgrade
|
| Total Debt Repaid | -1,020 | -1,041 | -1,151 | -331.71 | -626.93 | -936.91 | Upgrade
|
| Net Debt Issued (Repaid) | -695.04 | -721.09 | -835.11 | -128.51 | -291.32 | -143.72 | Upgrade
|
| Common Dividends Paid | -621.87 | -625.74 | -682.43 | -709.58 | -611.96 | -637.77 | Upgrade
|
| Other Financing Activities | -30.7 | -40.65 | -64.8 | 205.91 | 263.71 | 35.53 | Upgrade
|
| Financing Cash Flow | -1,348 | -1,387 | -1,582 | -632.18 | -639.57 | -745.96 | Upgrade
|
| Net Cash Flow | -1,058 | 600.65 | -2,507 | 1,965 | 1,603 | 1,088 | Upgrade
|
| Free Cash Flow | 238.48 | 1,937 | 1,528 | 2,582 | 2,265 | 1,862 | Upgrade
|
| Free Cash Flow Growth | -82.56% | 26.76% | -40.80% | 13.96% | 21.64% | 51.09% | Upgrade
|
| Free Cash Flow Margin | 0.45% | 3.69% | 3.02% | 5.20% | 4.98% | 4.01% | Upgrade
|
| Free Cash Flow Per Share | 0.32 | 2.57 | 2.03 | 3.42 | 3.00 | 2.47 | Upgrade
|
| Cash Income Tax Paid | 1,788 | 1,771 | 1,479 | 1,450 | 1,350 | 1,300 | Upgrade
|
| Levered Free Cash Flow | -341.52 | 1,198 | 14.86 | 2,185 | 2,073 | 1,497 | Upgrade
|
| Unlevered Free Cash Flow | -324.54 | 1,215 | 35.89 | 2,205 | 2,089 | 1,524 | Upgrade
|
| Change in Working Capital | 186.49 | 186.49 | -246.38 | 504.79 | 294.52 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.